Lipocine Inc (LPCN)
3.28 +0.09 (+2.82%) 04/28/25 [NASDAQ]
1.70 x 100 5.24 x 200
Realtime by (Cboe BZX)
1.70 x 100 5.24 x 200
Realtime - - (-) -
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | LPCN | NNVC | MTEX | ||
| Company | Lipocine Inc | Nanoviricides Inc | Mannatech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 3.14 | 1.4100 | 11.21 | ||
| High | 3.40 | 1.4200 | 11.90 | ||
| Low | 3.05 | 1.3200 | 10.99 | ||
| Last | 3.28 | 1.3400 | 11.25 | ||
| Change | +0.09 | -0.0800 | +0.50 | ||
| % Change | +2.82% | -5.63% | +4.65% | ||
| Volume | 12,500 | 59,500 | 4,800 | ||
| 20-Day Average Volume | 11,485 | 118,795 | 2,305 | ||
| Previous Close | 3.19 | 1.4200 | 10.75 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.08 | 1.2172 | 9.31 | ||
| 20-Day Raw Stochastic | 64.63% | 74.07% | 84.52% | ||
| 20-Day Relative Strength | 50.20% | 54.16% | 58.28% | ||
| Weighted Alpha | -36.51 | -11.10 | +27.10 | ||
| Today's Opinion | 72% Sell | 40% Sell | 56% Buy | ||
| Previous Opinion | 88% Sell | 24% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 80% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.97% since 04/21/25 | +3.08% since 04/21/25 | +18.42% since 04/16/25 | ||
| Low | 3.01 on 04/22/25 | 1.3000 on 04/23/25 | 9.40 on 04/22/25 | ||
| High | 3.40 on 04/28/25 | 1.4200 on 04/28/25 | 11.90 on 04/25/25 | ||
| 1-Month | |||||
| %Chg | unch since 03/28/25 | +10.74% since 03/28/25 | +19.43% since 03/25/25 | ||
| Low | 2.75 on 04/09/25 | 0.9400 on 04/09/25 | 7.70 on 04/03/25 | ||
| High | 3.57 on 04/01/25 | 1.4800 on 04/16/25 | 11.90 on 04/25/25 | ||
| 3-Month | |||||
| %Chg | -28.23% since 01/28/25 | +21.82% since 01/28/25 | -8.16% since 01/24/25 | ||
| Low | 2.75 on 04/09/25 | 0.9400 on 04/09/25 | 7.70 on 04/03/25 | ||
| High | 4.64 on 01/29/25 | 1.5500 on 02/24/25 | 16.49 on 01/29/25 | ||
| 6-Month | |||||
| %Chg | -40.90% since 10/28/24 | -11.84% since 10/28/24 | +49.60% since 10/25/24 | ||
| Low | 2.75 on 04/09/25 | 0.9400 on 04/09/25 | 7.22 on 10/28/24 | ||
| High | 6.17 on 11/04/24 | 1.6500 on 01/06/25 | 16.49 on 01/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,105 | 16,892 | 15,873 | ||
| Shares Outstanding, K | 5,350 | 15,641 | 1,901 | ||
| Annual Sales | 11,200,000 | 0 | 117,870,000 | ||
| Annual Net Income | 10,000 | -8,290,000 | 2,490,000 | ||
| Last Quarter Sales | 3,490,000 | 0 | 29,010,000 | ||
| Last Quarter Net Income | 1,780,000 | -2,030,000 | 2,260,000 | ||
| 60-Month Beta | 1.51 | 0.93 | 0.98 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 03/13/25 | -0.14 on 02/14/25 | 1.20 on 03/26/25 | ||
| Latest Earnings Date | 05/08/25 | 05/21/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | 0.200 on 06/14/23 | ||
| Next Ex-Dividends Date | N/A | N/A | 06/14/23 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 8.46 | ||